Retatrutide has to be dosed diligently, given that the dose needs to be increased steadily to minimize Unwanted effects. A standard starting dose for the first four weeks in phase two trials is 2mg/week. The gradual increase in dosage should last for a minimum of twelve weeks. As being a triple-receptor investigational therapy, this drugs ma